36 results
DEFM14A
GYRE
Gyre Therapeutics Inc
20 Jul 23
Proxy related to merger
8:57am
to increase manufacturer contributions in the catastrophic phase. The volume of drug pricing-related bills dramatically increased under the previous … be material.
In addition, many states have proposed or enacted legislation that seeks to indirectly or directly regulate pharmaceutical drug pricing
PRER14A
GYRE
Gyre Therapeutics Inc
15 May 23
Preliminary revised proxy
4:02pm
of drug pricing-related bills dramatically increased under the previous Congress, and the resulting impact on its business is uncertain and could … that seeks to indirectly or directly regulate pharmaceutical drug pricing, such as by requiring biopharmaceutical manufacturers to publicly report
PREM14A
zatd0i gtazkiya0cfr
30 Mar 23
Preliminary proxy related to merger
4:48pm
424B5
7j7qqvr9t49d4zgzs
28 Jan 21
Prospectus supplement for primary offering
4:11pm
424B5
2vjo6s2
26 Jan 21
Prospectus supplement for primary offering
4:07pm
424B5
e06mna 59nte
14 Feb 20
Prospectus supplement for primary offering
12:00am
424B5
csoeths0fx6nb2dd
12 Feb 20
Prospectus supplement for primary offering
4:17pm